CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN IN RENAL TRANSPLANT RECIPIENTS IS FOLLOWED BY AN IMPROVEMENT IN GLUCOSE METABOLISM | Publicación